Register entry
Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia LTDA
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 1
- Base
- ECU
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia LTDA | Av. Atahualpa s/n y Noboa y Caamano, Ambato, Tungurahua NONE, Ecuador (ECU) | Finished drug manufacture | 3001005102886776931 |
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human otc drug. By marketing category: OTC MONOGRAPH DRUG 2.
| Dosage form | NDCs |
|---|---|
| ointment | 1 |
| soap | 1 |
| Route | NDCs |
|---|---|
| topical | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| laboratorio neo farmaco del ecuador neofarmaco cia. ltda. | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Jabon Sulfuroso del Dr Pena | Sulfur Soap | soap, topical | 87845-102OTC MONOGRAPH DRUG |
| Yodo Salil | Ointment | ointment, topical | 87845-101OTC MONOGRAPH DRUG |
Compare
Comparable companies in ECU
- Laboratorios H.G. C.A.1 site · 3 NDC
Enquiry
Common questions
- Is Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia LTDA FDA approved?
- Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia LTDA holds 1 FDA-registered establishment in ECU. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia LTDA's drugs manufactured?
- The FDA register lists Ambato. Registered operations: finished drug manufacture.
- What drugs does Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia LTDA make?
- 2 products are listed under Laboratorio Neo Farmaco del Ecuador Neofarmaco Cia LTDA in the openFDA NDC Directory, most often as ointment; soap. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.